National Cancer Center, Tokyo, Japan.
Lady Hardinge Medical College & Associated Hospitals, Delhi, India.
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):681-690. doi: 10.31557/APJCP.2021.22.3.681.
The COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid- and long- term impact of COVID-19 to cancer care in Asia.
The two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures.
Participating stakeholders distilled five big questions. 1) "Will there be an explosion of late-stage cancers after the pandemic?" To address and recover from perceived delayed prevention, screening, treatment and care challenges, collaboration of key stakeholders in the region and alignment in cancer care management, policy intervention and cancer registry initiatives would be of essential value. 2) "Operations and Finance" The pandemic has resulted in significant material and financial casualties. Flagged acute challenges (shortages of supplies, imposition of lockdown) as well as longer-standing reduction of financial revenue, manpower, international collaboration, and training should also be addressed. 3) "Will telemedicine and technological innovations revolutionize cancer care?" Deploying and implementing telemedicine such as teleconsultation and virtual tumour boards were considered invaluable. These innovations could become a new regular practice, leading to expansion of tele-collaboration through collaboration of institutions in the region. 4) "Will virtual conferences continue after the pandemic?" Virtual conferences during the pandemic have opened new doors for knowledge sharing, especially for representatives of low- and middle-income countries in the region, while saving time and costs of travel. 5) "How do we prepare for the next pandemic or international emergency?" Roadmaps for action to improve access to appropriate patient care and research were identified and scrutinised.
Through addressing these five big questions, focused collaboration among members and with international organisations such as City Cancer Challenge will allow enhanced preparedness for future international emergencies.
.
新冠疫情对亚洲各地的医疗服务产生了巨大影响。亚洲国家癌症中心联盟和亚太癌症预防组织合作，评估了新冠疫情对亚洲癌症护理的中期和长期影响。
方法：这两个实体组织了一次联合研讨会，并在 17 个亚洲国家的主要癌症中心代表之间进行了会后交流，以概述主要挑战和应对措施。
结果：参与的利益相关者提出了五个大问题。1）“疫情后会不会出现晚期癌症的爆发？”为了解决和恢复人们对预防、筛查、治疗和护理方面的延迟认知，该地区的主要利益相关者的合作以及癌症护理管理、政策干预和癌症登记倡议的协调将具有至关重要的价值。2）“运营和财务”，疫情造成了重大的物质和财务损失。标记的急性挑战（供应短缺、封锁）以及长期的财务收入、人力、国际合作和培训减少也应得到解决。3）“远程医疗和技术创新是否会彻底改变癌症护理？”远程医疗的部署和实施，如远程咨询和虚拟肿瘤委员会，被认为是非常有价值的。这些创新可能会成为一种新的常规做法，通过该地区机构之间的合作扩大远程协作。4）“疫情后虚拟会议会继续吗？”疫情期间的虚拟会议为知识共享开辟了新的途径，特别是为该地区中低收入国家的代表提供了途径，同时节省了旅行的时间和成本。5）“我们如何为下一次大流行或国际紧急情况做准备？”确定并审查了改善获得适当患者护理和研究机会的行动计划路线图。
结论：通过解决这五个大问题，成员之间以及与城市癌症挑战赛等国际组织的重点合作将为未来的国际紧急情况做好更好的准备。
